glioma

Our Team

Meet Our Team

The Fine Lab brings together experimental and computational investigators whose projects address different levels of the same disease process. Work on patient-derived systems, regulatory biology, tumor–brain communication, treatment recovery, and predictive modeling is developed through direct collaboration among laboratory members. The aim is to preserve the depth of each investigator’s expertise while making the biological question, experimental assumptions, and interpretation of the data accessible across disciplines.

Primary Investigator

HF
Howard Fine , M.D.
  • Principal Investigator

Lab Members

Richa
Richa Singhania , Ph.D.
  • Assistant Professor, Cancer Neuroscience Research
  • University of Queensland, PhD (Molecular Biology)
JJ
Julien Jarroux-Ritchey , Ph.D.
  • Research Associate in Neuroscience
Research Focus:
Using cutting-edge sequencing and single-cell technologies to understand better the transcriptomic complexity that drives cell states in glioblastoma.
  • Institut Curie and Université Paris Sciences et Lettres, Ph.D.
aniket b
Aniket Bhattacharya , Ph.D.
  • Research Associate in Neuroscience
Research Focus:
Utilize GLICO model to track glioma-neuron-astrocyte connectivity using Optogenetics to “listen” to these secret conversations, learn the rules of the game and then, disrupt them using a combination of drugs and radiation.
  • Institute of Genomics and Integrative Biology, Ph.D.
Headshot of Karla Bonic
Karla Bonic , Ph.D.
  • Postdoctoral Associate in Neuroscience
Research Focus:

Glioblastoma treatment recurrence and how the current standard-of-care, particularly radiotherapy, might contribute to recurrence, and what interventions might disrupt this progression.

  • Oregon Health and Science University, Ph.D.
lilia
Lilia Brunetti , M.S.
  • Research Technician II
  • M.S., Georgetown University (Tumor Biology)
  • B.S., Indiana University (Biotechnology, Honors)
Yee Hoon!!
Yee Hoon Foong , PhD
  • Computational Biology Postdoc
Research Focus:
Develop in silico agent-based models parameterized by GLICO in vitro and in vivo datasets to track glioblastoma network coordination, calcium activity, and stress-induced swarm behavior, learning how glioma cells communicate to survive irradiation and immune cells in order to disrupt them
  • PhD, University of Pennsylvania (Genetics and Epigenetics)
  • B.S., University of Wisconsin-Madison (Molecular Biology, Honors)
Isha
Isha Monga , Ph.D.
  • Senior Bioinformatics Analyst
Research Focus:

Leveraging single-cell and spatial genomics to decipher glioblastoma evolution, tumor–microenvironment interactions, and therapeutic vulnerabilities using patient-derived cerebral organoid models.

  • Institute of Microbial Technology, Ph.D.
Stefano
Stefano Cirigliano , Ph.D.
  • Assistant Professor of Research, Neuroscience
  • Director of The Starr Foundation Cerebral Organoid Translational Core
Research Focus:

Developing clinically relevant, precision drug-screening platform for glioblastoma via our cerebral organoid glioma model, GLICO. 

 

  • Universidad Nacional de Quilmes, PhD (Cell Biology, Cancer Biology)

Interested? Join Us!

Weill Cornell Medicine Fine Lab 413 E 69th Street, 9th floor New York, NY 10021 Phone: (646) 962-6851